| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,464 |
2,290 |
$205K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
263 |
263 |
$39K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
58 |
36 |
$5K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
39 |
38 |
$40.50 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
516 |
486 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
32 |
30 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
121 |
118 |
$0.00 |
| 0518F |
|
27 |
26 |
$0.00 |
| 1100F |
|
27 |
26 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
325 |
310 |
$0.00 |
| 3288F |
|
27 |
26 |
$0.00 |
| M1007 |
>=50% of total number of a patient's outpatient ra encounters assessed |
116 |
114 |
$0.00 |
| 1170F |
|
94 |
93 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
95 |
88 |
$0.00 |
| M1003 |
Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy |
64 |
62 |
$0.00 |
| 1036F |
|
480 |
453 |
$0.00 |
| 1006F |
|
26 |
25 |
$0.00 |